Astellas Pharma Investor Relations Material
Latest events
Q4 2024
Astellas Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Astellas Pharma Inc
Access all reports
Astellas Pharma Inc., is a Japanese multinational pharmaceutical company that emerged from the merger between Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. in 2005. Astellas focuses on several key therapeutic areas including oncology, urology, immunology, cardiology, and infectious diseases, with a priority on research and development in infectious diseases, diabetes, gastrointestinal diseases, oncology, and central nervous system diseases. Astellas Pharma Inc. is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Key slides for Astellas Pharma Inc
Q4 2024
Astellas Pharma Inc
Q4 2024
Astellas Pharma Inc
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
🇯🇵 Japan